InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Tactic Pharma LLC. Director active across 1 company, notably Monopar Therapeutics. Cumulatively, 2 filings have been published. Split: 0 buy · 2 sells. Total volume traded: €30.9m. History available since 2 April 2025. The latest transaction was disclosed on 24 September 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations